ISAVUCONAZOLE AS PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS IN STEM CELL TRANSPLANT PATIENTS: A DESCRIPTIVE SINGLE CENTER EXPERIENCE.

EHA Library, Sergio Pinzon Mariño, 267984

EFFECTS OF DIFFERENT IRON FORMULATION SUPPORT ON SELECTION OF SOME PATHOGENS IN HUMAN GUT FLORA: MONOCENTRIC STUDY

EHA Library, GIULIO GIORDANO, 267985

CHANGES IN ERYTHROPOIESIS IN MALARIA-INDUCED ANEMIA

EHA Library, Raffaella Gozzelino, 267986

PLATELET INDICES, COAGULATION BIOMARKERS AND CARDIOVASCULAR RISK FACTORS IN TREATMENT-NAÏVE HIV-INFECTED ADULTS IN LAGOS UNIVERSITY TEACHING HOSPITAL

EHA Library, Yusuf Adelabu, 267987

UTILITY OF INFLAMMATORY MARKERS IN DISTINGUISHING VARIOUS INFECTIVE ETIOLOGIES OF FEVER IN FEBRILE NEUTROPENIC PATIENTS

EHA Library, Rohan Halder, 267988

CYTOMEGALOVIRUS INFECTION – A BRAKE IN PLATELET RECOVERY AFTER CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Viola Popov, 267989

DIAGNOSIS OF IRON DEFICIENCY ANAEMIA AND PARENTERAL IRON THERAPY: CLINICAL AUDIT IN A DISTRICT GENERAL HOSPITAL

EHA Library, Silvia Lovato, 267990

EFFICACY & SAFETY OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN IRON DEFICIENCY ANEMIA: A PROSPECTIVE STUDY

EHA Library, Uttam Kumar Nath, 267991

GROWTH/DIFFERENTIATION FACTOR-15, HEPCIDIN AND IRON METABOLISM BIOMARKERS IN LYMPHOPROLIFERATIVE DISEASES

EHA Library, Danijela Agić, 267992

COMPARATIVE ANALYSIS OF DEFERASIROX DISPERSIBLE TABLETS VS FILM-COATED TABLETS IN SEVERE CONGENITAL ANEMIAS: RESTROSPECTIVE STUDY IN A TERTIARY HOSPITAL

EHA Library, cristina insua vilas, 267993

DETECTION OF TREGS BY FLOW CYTOMETRY IN THE DIAGNOSIS OF HODGKIN LYMPHOMA

EHA Library, Barbara callegari, 267994

USING A FUNCTIONAL SCREEN TO IDENTIFY NOVEL ANTI-PROLIFERATIVE MIRNAS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Carla Sole, 267995

PHENOTYPIC IDENTIFICATION OF EBV-INFECTED LYMPHOCYTES FOR THE DIFFERENTIAL DIAGNOSIS OF HLH, CAEBV AND PTLD; A CLINICALLY APPLICABLE, FLOW-CYTOMETRY- BASED PERIPHERAL BLOOD ASSAY

EHA Library, Nicolas Martinez-Calle, 267996

STRONG EXPRESSION OF SLAMF7 IN NATURAL KILLER/T-CELL LYMPHOMA AND LARGE GRANULAR LYMPHOCYTE LEUKEMIA – A PROMINENT BIOMARKER AND POTENTIAL TARGET FOR ANTI-SLAMF7 ANTIBODY THERAPY

EHA Library, Ahmet ELMAAGACLI, 267997

ORBITAL LYMPHOMA: CLINICAL AND EPIDEMIOLOGICAL PATTERNS WITHIN THE UNITED STATES

EHA Library, Mahmoud KhalafAllah, 267998

PRE-CLINICAL BLOCKING OF PD-L1 MOLECULE, WHICH EXPRESSION IS DOWN REGULATED BY NF-B, JAK1/JAK2 AND BTK INHIBITORS, INDUCES REGRESSION OF ACTIVATED B-CELL LYMPHOMA.

EHA Library, Christelle VINCENT-FABERT, 267999

THE PROGNOSTIC ROLE OF MYOCYTE-SPECIFIC ENHANCER FACTOR 2C (MEF2C) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCL)

EHA Library, Maria Anastasiou, 268000

MYD88 L265P STATUS IN DIFFUSE LARGE B CELL LYMPHOMA, NOT OTHERWISE SPECIFIED. A SINGLE-CENTER STUDY FROM ARGENTINA.

EHA Library, Federico Jauk, 268001

THE UTILITY OF VARIABLE LEVELS OF CD39 EXPRESSION BY FLOW CYTOMETRY TO DISTINGUISHING B CELL LYMPHOMA SUBTYPES.

EHA Library, Rosa Di Gaetano, 268002

THE PROGNOSTIC IMPACT OF NUCLEOLIN OVEREXPRESSION IN HEMATOLOGIC NEOPLASMS

EHA Library, Marta Pereira, 268003

ESTABLISHMENT OF A KNOCKDOWN MODEL FOR UNRAVELLING THE PATHOGENESIS OF MANTLE CELL LYMPHOMA

EHA Library, Simone Valentin Hansen, 268004

HAIRY CELL VARIANT – LABORATORY FINDINGS OF A CASE SERIES

EHA Library, Marcal Silva, 268005

USE OF RNASCOPE TECHNOLOGY TO DETERMINE STAT-3 EXPRESSION IN HUMAN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Francesco Gaudio, 268006

DAMAGE OF THE TP53 GENE POLYADENYLATION SIGNAL IN DLBCL

EHA Library, Elena Voropaeva, 268007

PROGNOSTIC ROLE OF ACTIVE AND LATENT TRANSFORMING GROWTH FACTOR Β1 LEVELS IN BLOOD OF PATIENTS WITH NON-HODGKINS LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Vira Barilka, 268008

THE CASTLEMAN DISEASE: HISTOLOGICAL VARIANTS, POEMS-SYNDROME AND PRODUCTIVE PLASMA CELL VASCULITIS

EHA Library, Anatolii Mihailov, 268009

GENETIC VARIATIONS IN TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND RECEPTOR-1 (TRAIL-R1) GENE AND THE SUSCEPTIBILITY TO B CELL NON-HODGKIN LYMPHOMA IN EGYPT

EHA Library, Salwa Bakr, 268010

GENETIC MUTATION IN CYTOPENIC PATIENTS: DISTINCTIVE GENOMIC PROFILE BETWEEN PRECLINICAL VS. CLINICAL MYELODYSPLASTIC SYNDROME.

EHA Library, Kritnanan Songserm, 268011

DIFFERENT IRON FORMULATIONS MIGHT CHANGE METHYLATION PATTERNS AND BONE MARROW MACROPHAGES POLARIZATION IN LOW RISK MYELODYSPLASTIC SYNDROMES (LRMDS)

EHA Library, GIULIO GIORDANO, 268013

MOLECULAR CYTOGENETIC ANALYSIS OF CHROMOSOME 7 ABERRATIONS IN MYELOID DISEASES

EHA Library, Sarka Ransdorfova, 268014

THE CSF3R T618I MUTATION IS HIGHLY PREVALENT AMONG ATYPICAL CHRONIC MYELOID LEUKEMIA PATIENTS FROM SOUTH KOREA: A SINGLE CENTER EXPERIENCE

EHA Library, Seon Young Kim, 268015

A RELATIVE ADVANTAGE OF STEM CELL TRANSPLANTATION (SCT) IN PATIENTS WITH LESS ADVANCED MYELODYSPLASTIC DSYNDROMES (MDS)

EHA Library, Jaroslav Cermak, 268016

INCIDENCE OF MBL AT MDS DIAGNOSIS AND CLINICAL IMPLICATIONS

EHA Library, Vasileios Pardalis, 268017

ROLE OF SOMATIC MUTATIONS IN PATIENTS WITH HIGH-RISK MYELODISPLASTIC SYNDROMES TREATED WITH INTENSIVE CHEMOTHERAPY

EHA Library, Juan Carlos Caballero, 268018

HIGH INCIDENCE OF MALIGNANCY IN THE FAMILIES OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Aiman Hilal, 268019

PHENOTYPIC ALTERATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA: SIMILARITIES AND DIFFERENCES MYELODYSPLASTIC SYNDROMES

EHA Library, Irene Lorand-Metze, 268020

LONG-TERM TRANSFUSION FREEDOM IN MDS DEL(5Q) AFTER STOPPING LENALIDOMIDE TREATMENT

EHA Library, Freja Ebeling, 268021

ERYTHROPOIETIN IN LOW RISK MDS: DIFFICULT TO CONVINCE FOR SAFETY DUE TO AFFORDABILITY; AN EXPERIENCE FROM PAKISTAN

EHA Library, Nida Anwar, 268022

ENVIRONMENTAL AND OCCUPATIONAL DETERMINANTS OF MYELODYSPLASTIC SYNDROMES: EXPOSURE, ASSOCIATION AND RISK: A CASE CONTROL STUDY FROM PAKISTAN.

EHA Library, Nida Anwar, 268023

LOW RISK MYELODYSPLASTIC SYNDROMES (LRMDS) RESPONSE TO ERYTHROPOIETIN MIGHT BE ENHANCED BY DIFFERENT IRON FORMULATION INFLUENCING BONE MARROW METILATION PATTERNS AND MACROPHAGES POLARIZATION

EHA Library, GIULIO GIORDANO, 268024

PROGNOSTIC VALUE OF CLINICAL AND CYTOGENETIC PARAMETERS IN PATIENTS WITH　MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE

EHA Library, Yasuyuki Takahashi, 268025

SAFETY OF GENERIC AZACITIDINE IN MYELOID NEOPLASMS – A SINGLE CENTRE EXPERIENCE

EHA Library, Nurul Aidah Abdul Halim, 268026

THE GENETIC PROFILE OF THE PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES IN ALBANIA ( 2009-2013)

EHA Library, Adela Perolla, 268027

AZACYTIDINE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS INFERIOR TO HD/ARA-C WITH RESPECT TO RELAPSE FOLLOWING TRANSPLANTATION

EHA Library, Mufide OKAY, 268028

HOST INFLAMMATORY FACTORS MIGHT PREDICT LEUKEMIC TRANSFORMATION AND OVERALL SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Yanitsa Davidkova, 268029

CLINICAL, PARACLINICAL CHARACTERISTICS AND OUTCOME IN ALGERIAN MYELODYSPLASTIC SYNDROMES : A SINGLE CENTER EXPERIENCE

EHA Library, Talbi Faiza, 268030

A SINGLE CENTRE EXPERIENCE WITH AZACITIDINE FOR MDS, AML AND CMML IN RELATION TO CYTOGENETIC RISK AND PERFORMANCE STATUS.

EHA Library, Catherine PAGE, 268031

METABOLIC STARVATION TRIGGERED BY L-ASPARAGINASE SENSITIZES MULTIPLE MYELOMA CELLS TO PROTEASOME INHIBITORS BY INDUCING DNA DAMAGE ACCUMULATION

EHA Library, Paola Minetto, 268032

PATIENT-SPECIFIC MULTIPLE MYELOMA MODEL USING 3D PRINTED ORGANOIDS FOR PREDICTING AND UNDERSTANDING TREATMENT RESPONSE.

EHA Library, Cesar Rodriguez, 268033

MULTI-BIOMARKER NORMALIZATION OF MM SERUM PATIENTS AS POSSIBLE GATEWAY FOR BONE MARROW MRD BY MULTIPARAMETER FLOW CYTOMETRY

EHA Library, Carmen Quiñones-Torrelo, 268034

FUNCTIONAL SIGNIFICANCE OF OVEREXPRESSION OF MITOTIC CHECKPOINT PROTEIN BUB1 IN MULTIPLE MYELOMA

EHA Library, YUTO FUJIBAYASHI, 268035

A SAME DAY ASSAY USING CYTOCHROME C RELEASE DETERMINES SENSITIVITY TO COOPERATIVE BCL-2 AND MCL-1 TARGETING IN MULTIPLE MYELOMA CELL LINES AND PRIMARY SAMPLES

EHA Library, Martin Grundy, 268036

TRANSCRIPTOME ANALYSIS AFTER DEXAMETHASONE EXPOSURE DIFFERENTIATES RESPONSE TO GLUCOCORTICOIDS IN MULTIPLE MYELOMA

EHA Library, Patryk Krzeminski, 268037

INHIBITION OF NUCLEOLIN REVERSED BORTEZOMIB RESISTANCE VIA THE REGULATION OF NF-ΚB PATHWAY IN MULTIPLE MYELOMA CELLS

EHA Library, Jianda Hu, 268038

RESULTS OF BONE DENSITOMETRY IN PATIENTS WITH MULTIPLE MYELOMA DURING TREATMENT

EHA Library, Alexeev Sergey, 268039

UPREGULATION OF PD-1 CHECKPOINT RECEPTOR MOLECULE ON BONE MARROW T-CELLS FROM PATIENTS WITH MULTIPLE MYELOMA, AND ITS POTENTIAL IMPACT ON CLINICAL OUTCOME

EHA Library, Jaime PEREZ DE OTEYZA, 268040

CIRCULATING PLASMA CELLS: AN APPROACH BASED ON NEXT GENERATION FLOW TOOLS IN MONOCLONAL GAMMAPATHIES

EHA Library, Federico Torreguitart, 268041

NICHEFORMING STRUCTURES OF BONE MARROW OF PATIENTS WITH MULTIPLE MYELOMA BEFORE AND AFTER AUTOHSCT

EHA Library, Natalya Semenova, 268042

MRD ANALYSIS IN MULTIPLE MYELOMA: IMMUNOGLOBULIN NGS VERSUS ASO-PCR

EHA Library, Jona Van der Straeten, 268043

DIGITAL ENUMERATION OF PLASMA CELL BURDEN BY MUM1 IMMUNOPHENOTYPING: IMPLICATIONS FOR MULTIPLE MYELOMA DIAGNOSTICS

EHA Library, Jacques Malherbe, 268044

COEXISTENCE OF MONOCLONAL B- CELL POPULATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; INCIDENCE, IMMUNOPHENOTYPING AND CLINICAL CHARACTERIZATION

EHA Library, Yael Cohen, 268045

NEUTROPHILIC LEUKEMOID REACTION ASSOCIATED WITH SMOLDERING MULTIPLE MYELOMA

EHA Library, Humberto Martínez-Cordero, 268046

NRF1-DEPENDENT PATHWAY: SALVAGE PATHWAY AFTER THE PROTEASOME INHIBITION IN MULTIPLE MYELOMA AND MANTLE CELL LYMPHOMA?

EHA Library, Dominika Fassmannová, 268047

THE EFFECT OF WHOLE-BODY MRI DATA ON PFS IN PATIENTS WITH MM IN STRICT COMPLETE REMISSION AFTER AUTO-HSCT

EHA Library, Maxim Solovev, 268048

CLINICAL PRESENTATION AND OUTCOMES OF SOLITARY PLASMACYTOMA IN A LARGE TERTIARY HOSPITAL: A RETROSPECTIVE COHORT STUDY.

EHA Library, Charles AGBUDUWE, 268049

POST-TREATMENT IMMUNE RECONSTITUTION IN MYELOMA IS ASSOCIATED WITH IMPROVED PROGRESSION FREE SURVIVAL IN THE ERA OF NOVEL THERAPY; A RETROSPECTIVE ANALYSIS IN AN AUSTRALIAN HAEMATOLOGY DEPARTMENT

EHA Library, Shivam Agrawal, 268050

VELCADITO. A PHASE II TRIAL WITH LOW DOSES OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE FOR ELDERLY PATIENTS (>75Y) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Ernesto Pérez Persona, 268051

THE IMPACT OF RVD OR VCD INDUCTION ON RESPONSE 3 MONTH AFTER FIRST LINE AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA. A SINGLE_CENTER RETROSPECTIVE ANALYSIS.

EHA Library, Jakob Nordberg Nørgaard, 268052

SYMPTOM BURDEN AND OXIDATIVE STRESS IN MULTIPLE MYELOMA PATIENTS IN EARLY POST-TRANSPLANTATION PERIOD

EHA Library, Anastasiia Zherniakova, 268053

BORTEZOMIB-HIGH DOSE METHYLPREDNISOLONE OFFERS IMPROVED HAEMATOLOGICAL RESPONSES AND OVERALL SURVIVAL COMPARED TO BORTEZOMIB-DEXAMETHASONE IN SYSTEMIC LIGHT CHAIN AMYLOIDOSIS

EHA Library, Ayesha Shameem Mahmood, 268054

PRETREATMENT D-DIMER LEVELS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Peipei Xu, 268055

REAL-WORLD ITALIAN EXPERIENCE OF POMALIDOMIDE IN RELAPSED-REFRACTORY MYELOMA: RETROSPECTIVE MULTICENTER STUDY BY THE RETE EMATOLOGICA PUGLIESE AND BASILICATA

EHA Library, Giuseppe Mele, 268056

CTDA VERSUS MPT FOR MULTIPLE MYELOMA: REAL WORLD DATA FROM THE WEST OF SCOTLAND CANCER NETWORK

EHA Library, Matt Steel, 268057

DARATUMUMAB MONOTHERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA REAL CLINICAL PRACTICE. A MULTICENTRIC RETROSPECTIVE STUDY.

EHA Library, Álvaro Lorenzo-Vizcaya, 268058

THE IMPACT OF COMORBIDITY ON OVERALL SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Evgeniy Mikhailov, 268059

VALIDATION OF THE BOSTON UNIVERSITY STAGING SYSTEM IN AL AMYLOIDOSIS

EHA Library, Peter Mollee, 268060

DO FUNCTIONAL VARIANTS OF MIF AND MBL GENES INFLUENCE OUTCOME IN PATIENTS UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA?

EHA Library, Mustafa Pehlivan, 268061

LIGHT CHAIN (AL) AMYLOIDOSIS: A SINGLE CENTRE EXPERIENCE AND THE EFFECTIVENESS OF BORTEZOMIB BASED THERAPY AS FIRST LINE THERAPY

EHA Library, Henry Ngu, 268062

IMPACT OF OVERWEIGHT IN TREATMENT WITH DARATUMUMAB IN MULTIPLE MYELOMA PATIENTS

EHA Library, Adriana Roque, 268063

IMPACT OF EXTRAMEDULLARY DISEASE IN THE OUTCOMES OF MEXICAN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Ana Cesar, 268064

FEATURES OF THE DIRECT ANTIGLOBULIN TEST IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Elena Poponina, 268065

BUSULFAN/CYCLOPHOSPHAMIDE (BU/CY) COMPARED WITH HIGH-DOSE MELPHALAN (HDMEL) AS CONDITIONING REGIMEN FOR AUTO STEM CELL TRANSPLANTATION OF MULTIPLE MYELOMA

EHA Library, Chengcheng Fu, 268066

HEPATITIS B VIRUS INFECTION MIGHT CONTRIBUTE TO MULTIPLE MYELOMA PROGRESSION THROUGH 1Q21 AMPLIFICATION

EHA Library, Peipei Xu, 268067

POMALIDOMIDE AND DEXAMETHASONE IN RELAPSING POEMS SYNDROME: A FRENCH REPORT OF 5 CASES.

EHA Library, Camille GOLFIER, 268068

SINGLE AGENT DARATUMUMAB IN VERY ADVANCED RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL-LIFE SINGLE CENTER RETROSPECTIVE STUDY

EHA Library, Maxime Jullien, 268069

AL AMYLOIDOSIS IN THE CHILEAN PUBLIC HEALTH SYSTEM: A PENDING DEBT. MULTICENTER STUDY OF THE CHILEAN HEMATOLOGICAL COOPERATIVE GROUP (PANDA).

EHA Library, Hernan Lopez Vidal, 268070

NUMBER OF INVOLVED BONE REGIONS IS A SIMPLE AND USEFUL PREDICTIVE MARKER OF EARLY DISEASE PROGRESSION AND DEATH IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, Katsuya Fujimoto, 268071

EFFICACY AND SAFETY OF THE ANTITUMOR RVP PROGRAM (LENALIDOMIDE, BORTEZOMIB, PREDNISONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Кирилл Белоусов, 268072

HEPATITIS B VIRUS INFECTION MIGHT CONTRIBUTE TO MULTIPLE MYELOMA PROGRESSION THROUGH 1Q21 AMPLIFICATION

EHA Library, Peipei Xu, 268073

THE ROLE OF THE BONE MARROW MICROENVIRONMENT AND CYTOKINES IN THE PROGRESSION OF MONOCLONAL GAMMAPATHY AND MULTIPLE MYELOMA IN PATIENTS OF THE GOMEL REGION OF BELARUS

EHA Library, Zhanna Kozich, 268074

MENTAL HEALTH AND QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE

EHA Library, Yasushi Hiramatsu, 268075

ONLINE CME SIGNIFICANTLY IMPACTS MULTIPLE MYELOMA CLINICIANS: EXPERIENCE FROM A MULTI-YEAR CURRICULUM WITH 33,699 LEARNERS

EHA Library, Lauren Willis, 268076

RISK FACTORS ASSOCIATED WITH EARLY MORTALITY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Anna Novikova, 268077

CHARACTERISTICS AND REAL-WORLD TREATMENT OUTCOMES IN MULTIPLE MYELOMA YOUNG PATIENTS: A SINGLE CENTER MOROCCAN EXPERIENCE

EHA Library, Mahtat EL MEHDI, 268078

POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (PCD) IS AN EFFECTIVE SALVAGE REGIMEN FOR MULTIPLE MYELOMA (MM) PATIENTS RELAPSED ON OR REFRACTORY TO DARATUMUMAB

EHA Library, Annamaria Brioli, 268079

CHOLESTEROL LEVELS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Peipei Xu, 268080

REAL LIFE EXPERIENCE OF TREATMENT WITH POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE COMBINATION IN ADULT PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Carolina ALARCÓN-PAYER, 268081

INCIDENCE & SEVERITY OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY WITH THE USE OF GENERIC BORTEZOMIB IN MONOCLONAL GAMMOPATHIES: A PROSPECTIVE STUDY FROM INDIA

EHA Library, Uttam Kumar Nath, 268082

CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE “ON DEMAND” IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: REAL LIFE EXPERIENCE AND NEW PERSPECTIVES ON DOSE-DENSE CHEMOTHERAPY.

EHA Library, Antonio Giordano, 268083

PROGNOSTIC VALUE OF SERUM FREE LIGHT CHAIN IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Наталия Скворцова, 268084